Enalaprilat dihydrate
SIGMA/E9658 - ≥98% (HPLC)
Synonym: (2S)
CAS Number: 84680-54-6
Empirical Formula (Hill Notation): C18H24N2O5 ·2H2O
Molecular Weight: 384.42
EC Number: 278-459-3
MDL Number: MFCD00941393
Linear Formula: C18H24N2O5 ·2H2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| InChI | 1S/C18H24N2O5.2H2O/c1-12( |
| InChI key | MZYVOFLIPYDBGD-MLZQUWKJSA |
| originator | Merck & Co., Inc., Kenilworth, NJ, U.S. |
| Quality Level | 100 ![]() |
| SMILES string | O.O.C[C@H](N[C@@H](CCc1cc |
| solubility | DMSO: 64 mg/mL |
| H2O: 14 mg/mL at 60 °C (warming for 5 minutes) | |
| storage temp. | room temp |
| Biochem/physiol Actions: | Enalapril, the ethyl ester of enalaprilat exhibits slight pharmacological activity until it is hydrolyzed in the liver to enalaprilat. Enalaprilat, a IV form of an angiotensin-converting-en |
| Biochem/physiol Actions: | Enalaprilat is an inhibitor of angiotensin converting enzyme (ACE), antihypertensive, and a Bradykinin B1 receptor activator. |
| Biochem/physiol Actions: | Enalaprilat is an inhibitor of angiotensin converting enzyme (ACE), antihypertensive, and a Bradykinin B1 receptor activator. Enalaprilat has nM potency versus ACE and also activates B1 receptors to release NO. |
| Features and Benefits: | This compound is featured on the Angiotensin Receptors and Bradykinin Receptors pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S. . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |

